HK:2197 Stock Latest News
Company AnnouncementsClover Posts Strong Phase 2 Data for Combination Respiratory Vaccines in Older Adults2M ago2197
Company AnnouncementsClover Biopharmaceuticals Swings to Profit on GAVI Gain as Cash Levels Tighten2M ago2197
Company AnnouncementsClover Biopharmaceuticals Sets Board Meeting to Approve Interim Results and Consider Dividend2M ago2197
Company AnnouncementsClover Biopharmaceuticals Signals Interim Profit on One-Off Gavi Settlement Gain3M ago2197
Company AnnouncementsClover Biopharmaceuticals Wins Shareholder Backing for All AGM Resolutions4M ago2197
Company AnnouncementsClover Biopharmaceuticals Tightens Insider Trading Compliance After Governance Review5M ago2197Company AnnouncementsClover Biopharmaceuticals Sets 2026 AGM to Renew Board Mandates and Share Issuance Authority5M ago2197
Company AnnouncementsClover Biopharmaceuticals Details Capped Payment Deal With Gavi, Easing US$224 Million Exposure7M ago2197
Company AnnouncementsClover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines7M ago2197
Company AnnouncementsClover Biopharmaceuticals Grants Over 19 Million Equity Awards to Align Pay With Performance7M ago2197
Company AnnouncementsClover Narrows Loss as It Cuts Costs and Refocuses on Respiratory Vaccines7M ago2197- Company AnnouncementsClover posts strong RSV re-vaccination data in head-to-head trial with GSK7M ago2197
Company AnnouncementsClover Biopharmaceuticals Strikes Cap-Limited Settlement With Gavi to End Arbitration7M ago2197Company AnnouncementsClover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend7M ago2197
Company AnnouncementsClover Launches Phase 2 Trial of Combination Respiratory Vaccines in Older Adults9M ago2197
Company AnnouncementsClover Biopharmaceuticals Reports Positive Phase I Results for Respiratory Vaccines1y ago2197
Company AnnouncementsClover Biopharmaceuticals Reports Interim Financial Results for 20251y ago2197
Company AnnouncementsClover Biopharmaceuticals to Review Interim Financial Results and Dividend Proposal1y ago2197
Company AnnouncementsClover Biopharmaceuticals Announces Board and Committee Changes1y ago2197
Company AnnouncementsClover Biopharmaceuticals Strengthens Governance with New Nomination Committee1y ago2197Company AnnouncementsClover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement1y ago2197
Company AnnouncementsClover Biopharmaceuticals Launches Phase I Trial for New Respiratory Vaccines1y ago2197
